| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 3.5K | 1.3% | 46.1% |
| Total Income | 3.5K | 0.3% | 43.7% |
| Expenditure | 3.1K | 6.3% | 49.0% |
| PBT | 387.61 | 33.4% | 11.7% |
| Net Profit | 291.13 | 32.6% | 10.0% |
| OPM | 17.97% | 3.02pp | 2.89pp |
| NPM | 8.24% | 3.96pp | 2.52pp |
| EPS | 15.06 | 32.6% | 10.1% |
Detailed report is being prepared.
Margin recovery on the line as BKT turns to price, prepares car tyre pivot
Balkrishna Industries faces a margin test in Q2 FY27: full benefits of Q1's 5% price hikes should flow through, but off-highway volume headwinds and commodity costs persist. The real story is execution—new car tyre launch set for November, Pirelli partnership signaling a strategic turn.
What to Expect
~₹2,150–₹2,200 Cr
Price-driven growth offsetting global off-highway volume headwinds; Q1 price hikes flow fully
13–14% (target)
Recovery from weak Q2 FY26 (9.8%); commodity costs moderating YoY
~₹270–₹290 Cr
On-track if margins recover; Q2 FY26 fell 21% YoY to ₹273 Cr
Q4 FY26 + special
Jul interim dividend ₹4/share approved; final expected at board approval (Nov 4)
A strong quarter would show EBITDA margins back above 14%, validating price realization and cost discipline amid inflation. Weak would be margin compression below 13% or volume decline steeper than expected—signaling off-highway weakness persisting or price leverage erosion.
On Track?
BKT is tracking full-year guidance. Management signaled ₹3,000 Cr CapEx for FY27 (targeting ₹23,000 Cr revenue by FY30) and committed to the car tyre pivot via new capacity and the Pirelli partnership. Q2 FY26 was a trough (revenue down 1.8% YoY, profit down 21%), so Q2 FY27 represents the inflection: price sticks, volumes stabilize, and the margin recovery narrative takes shape. The real test is execution on the November car tyre launch and ramping US contribution toward the 10% volume target.
What the Street Says
Since Last Quarter
1 · Pirelli Partnership (Oct 22–27, 2026)
BKT and Pirelli signed framework agreement for 50:50 JV and offtake agreement. Target: 800k premium car tyres (PCR) annually by 2030, with production starting in 2027. No earnings impact Q2, but signals major pivot from off-highway-heavy model to on-highway consumer segment. Share price rallied 3.9% on announcement.
2 · Car Tyre Launch (November 2026)
BKT plans in-India car tyre launch in November—weeks after this result. Results will not yet reflect volume, but sets up FY28 story. US market contribution targeted at 10% of volume in FY27 (early stages).
3 · ₹550 Cr NCD Issuance (Aug–Sep 2026)
Finance committee approved non-convertible debentures to fund CapEx. Rated, private placement tranches. Reflects capital intensity of expansion into car tyres.
4 · Interim Dividend ₹4/share (July 2026)
First interim dividend for FY27 approved (200% payout). Final dividend decision pending Nov 4 approval.
5 · Tax Demand ₹1.05 Cr (Sep 2026)
CGST adjudication order from Bhuj Division (Sep 21). Routine compliance matter; immaterial to bottom line. Trading window closed Oct 1 until 48h post-result.
What to Watch on Result Day
The setup: BKT is at a pivot point—Q2 marks the inflection from margin compression to recovery if price realization sticks and costs moderate. The street is neutral but watching execution on the strategic pivot to car tyres. Here are the three things that will define the narrative:
1 · Margin trajectory clarity
EBITDA margin recovery above 14% validates price realization and cost control. Anything below 13% signals that off-highway weakness or commodity pressures persist—a red flag for the pivot story.
2 · Volume and mix narrative
What happened to export volumes? Is the off-highway segment stabilizing or still under pressure? Early signs of car tyre ramp or still minimal? Color on US sales (tracking toward 10% FY27 target) and India domestic growth sets up investor confidence in the November launch.
3 · Capital expenditure and FY30 trajectory
Management guided ₹3,000 Cr CapEx for FY27 targeting ₹23,000 Cr FY30 revenue. Q2 run-rate on capex, plant readiness for November car tyre production, and Pirelli JV timeline color in the medium-term story.
Balkrishna Industries reports November 4 in a tight window: results land two days before the car tyre launch that could reshape the business. The Street is neutral, waiting to see whether price discipline holds, margins recover, and execution on the strategic pivot to consumer segments (cars + Pirelli partnership) stays credible. Q2 FY26 was a trough; Q2 FY27 should show the inflection. Watch margin recovery, volume mix trends, and forward capex guidance—they'll signal whether the turnaround has legs.